|
2023
|
Invention
|
Compounds and methods of preparing compounds s1p1 modulators.
The present embodiments are direct... |
|
|
Invention
|
5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of usi... |
|
|
Invention
|
Compounds for modulating s1p1 activity and methods of using the same.
The present embodiments ar... |
|
2022
|
Invention
|
Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating comp... |
|
|
Invention
|
Beta-arrestin effectors and compositions and methods of use thereof.
This application describes ... |
|
|
Invention
|
6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of usi... |
|
2021
|
Invention
|
7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of usi... |
|
|
Invention
|
Crystalline and amorphous forms of a delta-opioid modulator.
The present disclosure provides nov... |
|
|
Invention
|
Crystalline and amorphous forms of a delta-opioid modulator. The present disclosure provides nove... |
|
|
Invention
|
Opioid receptor ligands and methods of using and making same. This application describes compound... |
|
|
Invention
|
Β-arrestin effectors and compositions and methods of use thereof. This application describes a fa... |
|
|
G/S
|
Pharmaceutical and biological preparations used in pain management and the treatment of pain. |
|
|
G/S
|
Pharmaceutical and biological preparations used in pain
management and the treatment of pain. |
|
2020
|
Invention
|
Compounds and methods of preparing compounds s1p1 modulators. The present embodiments are directe... |
|
|
G/S
|
Pharmaceutical and biological preparations used in pain management and the treatment of pain |
|
|
Invention
|
Methods of treating epilepsy using the same.
The present embodiments are directed, in part, to c... |
|
|
Invention
|
Methods of treating epilepsy using the same. The present embodiments are directed, in part, to co... |
|
|
Invention
|
Methods of treating hyperalgesia.
This application describes compounds and methods that can be u... |
|
2018
|
Invention
|
Compounds for modulating s1p1 activity and methods of using the same. 1 receptor and methods of u... |
|
|
Invention
|
Compounds for modulating s1p1 activity and methods of using the same. The present embodiments are... |
|
|
Invention
|
7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using a... |
|
2017
|
Invention
|
Synthesis of beta-arrestin effectors.
Embodiments disclosed herein provide compounds and methods... |
|
2016
|
Invention
|
Combinations of opioid receptor ligands and cytochrome p450 inhibitors.
This application describ... |
|
|
Invention
|
Combinations of opioid receptor ligands and cytochrome p450 inhibitors. This application describe... |
|
|
Invention
|
Methods of treating hyperalgesia. This application describes compounds and methods that can be us... |
|
|
Invention
|
Crystalline and amorphous forms of a beta-arrestin effector.
The present disclosure provides nov... |
|
|
G/S
|
Pharmaceutical and biological preparations used in pain management and the treatment of pain |
|
|
Invention
|
Beta-arrestin effectors and compositions and methods of use thereof. This application describes a... |
|
2015
|
Invention
|
Synthesis of beta-arrestin effectors. Embodiments disclosed herein provide compounds and methods ... |
|
2014
|
G/S
|
Research and development in the pharmaceutical and biopharmaceutical fields, namely technologies ... |
